Emerging trends in microbiological diagnostics in children

Area of Science:

• Public Health
• Infectious Diseases
• Pediatrics

Background:

• The World Health Organization (WHO) and United Nations (UN) aim to end the global tuberculosis (TB) epidemic.
• The "Find. Treat. All #EndTB" initiative targets universal access to TB diagnosis, treatment, and care by 2022.
• Achieving these targets in pediatric populations requires specialized approaches.

Purpose of the Study:

• To highlight the importance of newer diagnostic tools for TB in children.
• To emphasize the need for microbiological confirmation and universal drug sensitivity testing in pediatric TB cases.
• To align with global strategies for TB elimination.

Main Methods:

• Review of current trends in pediatric TB diagnostics.
• Focus on advancements enabling microbiological confirmation.
• Emphasis on assessing drug sensitivity in children.

Main Results:

• Newer diagnostics are increasingly vital for pediatric TB case finding.
• Microbiological confirmation is becoming more accessible for children.
• Universal drug sensitivity testing is a key trend for effective treatment.

Conclusions:

• Advancements in diagnostics are essential for meeting global TB targets in children.
• Improved diagnostic capabilities facilitate timely and accurate treatment decisions.
• The focus on microbiological confirmation and drug sensitivity is critical for controlling TB in pediatric populations.